What is Hypothalamic Obesity?

What is Hypothalamic Obesity? Hypothalamic obesity (HO) is a rare health problem that happens when part of the brain called the hypothalamus gets injured or does…

X-Linked Hypophosphatemia Management in Children: An International Working Group Clinical Practice Guideline

X-Linked Hypophosphatemia Management in Children: An International Working Group Clinical Practice Guideline This important resource provides healthcare practitioners with expert recommendations that will help guide the…

Persistent Growth-promoting effects of vosoritide in children with achondroplasia are accompanied by improvements in physical and social aspects of health related quality of life

Publication of impact on health-related quality of life from 3 year data with vosoritide. These data suggest that after 3 years of treatment, vosoritide demonstrates a…

International Consensus Guidelines on the Implementation and Monitoring of Vosoritide Therapy in Individuals with Achondroplasia

Since the approval of vosoritide in 2021, a need was created for a treatment guideline for support clinicians. An international collaborative of leading experts and patient…

PES Lipid SIG Diabetes and Lipids Algorithm

International Consensus Statement on the diagnosis, multidisciplinary management and lifelong care of individuals with achondroplasia

Achondroplasia is the most common skeletal dysplasia and is characterized by a variety of medical, functional and psychosocial challenges across the lifespan. There is variability in…

Triaging and initial treatment in the patient with suspected type 2 diabetes

Triaging and initial treatment in the patient with suspected type 2 diabetes

These treatment pathways were developed by the type 2 diabetes subgroup of the PES Diabetes SIG, using evidence base when available in combination with expert clinical…

Lipid SIG Algorithms

Lipid management algorithms were developed by SIG members as a resource for use in clinical care and trainee education. Relevant guidelines were applied in the development…

Anti Obesity Medication Guideline

The prevalence of obesity and associated comorbidities is rising. This material summarized the anti-obesity medications adapted by the PES Obesity Special Interest Group from the original…